Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34 + -selected allogeneic transplantation.
Christina ChoPatrick HildenScott T AvecillaJuliet N BarkerHugo Castro-MalaspinaSergio A GiraltBoglarka GyurkoczaAnn A JakubowskiMolly A MaloyRichard J O'ReillyEsperanza B PapadopoulosJonathan U PeledDoris M PonceBrian ShafferRoni TamariMarcel R M van den BrinkJames W YoungPere BarbaMiguel-Angel PeralesPublished in: Advances in cell and gene therapy (2020)
The data that support the findings of this study are available on request from the corresponding author, C Cho. In order to protect the privacy of research participants, the data are not publicly available.